PMV Pharmaceuticals, Inc. (PMVP)
1.35
+0.01
(+0.75%)
USD |
NASDAQ |
Sep 09, 13:07
PMV Pharmaceuticals Market Cap : 72.17M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 71.64M |
| September 04, 2026 | 68.96M |
| September 03, 2026 | 66.29M |
| September 02, 2026 | 67.36M |
| September 01, 2026 | 68.96M |
| August 31, 2026 | 64.69M |
| August 28, 2026 | 65.22M |
| August 27, 2026 | 66.29M |
| August 26, 2026 | 70.03M |
| August 25, 2026 | 69.77M |
| August 24, 2026 | 69.77M |
| August 21, 2026 | 71.10M |
| August 20, 2026 | 69.50M |
| August 19, 2026 | 68.43M |
| August 18, 2026 | 66.29M |
| August 17, 2026 | 66.83M |
| August 14, 2026 | 67.36M |
| August 13, 2026 | 64.95M |
| August 12, 2026 | 67.36M |
| August 11, 2026 | 69.50M |
| August 10, 2026 | 65.60M |
| August 07, 2026 | 63.46M |
| August 06, 2026 | 62.93M |
| August 05, 2026 | 62.40M |
| August 04, 2026 | 62.40M |
| Date | Value |
|---|---|
| August 03, 2026 | 59.73M |
| July 31, 2026 | 59.20M |
| July 30, 2026 | 60.26M |
| July 29, 2026 | 57.06M |
| July 28, 2026 | 58.66M |
| July 27, 2026 | 62.93M |
| July 24, 2026 | 66.13M |
| July 23, 2026 | 70.93M |
| July 22, 2026 | 70.93M |
| July 21, 2026 | 69.86M |
| July 20, 2026 | 68.26M |
| July 17, 2026 | 71.46M |
| July 16, 2026 | 69.33M |
| July 15, 2026 | 74.66M |
| July 14, 2026 | 75.73M |
| July 13, 2026 | 68.26M |
| July 10, 2026 | 66.13M |
| July 09, 2026 | 66.13M |
| July 08, 2026 | 66.66M |
| July 07, 2026 | 66.13M |
| July 06, 2026 | 64.26M |
| July 02, 2026 | 65.06M |
| July 01, 2026 | 66.13M |
| June 30, 2026 | 71.46M |
| June 29, 2026 | 68.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.785B |
| Alnylam Pharmaceuticals, Inc. | 34.14B |
| Anika Therapeutics, Inc. | 279.97M |
| Savara, Inc. | 1.108B |
| Vericel Corp. | 1.991B |
Market Cap Related Metrics
| Price to Book Value | 1.009 |
| Price | 1.35 |
| Earnings Yield | -104.7% |